Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500106489Phase 4Recruiting
Phase 4, randomised trial of ropivacaine in caesarean delivery (C-section) (2 arms), sponsored by Foshan First People's Hospital. Primary endpoint: Incidence of post-anesthesia hypotension. Started Jul 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500106489.